Trypanotolerance in N’Dama x Boran crosses under natural trypanosome challenge: effect of test-year environment, gender, and breed composition by Caleb O Orenge et al.
Orenge et al. BMC Genetics 2012, 13:87
http://www.biomedcentral.com/1471-2156/13/87RESEARCH ARTICLE Open AccessTrypanotolerance in N’Dama x Boran crosses
under natural trypanosome challenge:
effect of test-year environment, gender,
and breed composition
Caleb O Orenge1,2*, Leonard Munga2, Charles N Kimwele3, Steve Kemp4,5, Abraham Korol6, John P Gibson7,
Olivier Hanotte8 and Morris Soller9Abstract
Background: Trypanosomosis, a protozoal disease affecting livestock, transmitted by Glossina (tsetse) flies is a
major constraint to agricultural production in Sub-Saharan Africa. It is accepted that utilization of the native
trypanotolerance exhibited in some of the African cattle breeds to improve trypanotolerance of more productive
but susceptible breeds, will offer a cost effective and sustainable solution to the problem. The success of this
approach is based on the premise that quantitative trait loci previously identified under relatively controlled
situations confer useful trypanotolerance under natural field situations. As part of a study to authenticate this
hypothesis, a population of 192 cattle, consisting of six batches of N’Dama and Kenya-Boran backcross animals
[(N’Dama x Kenya-Boran) x Kenya-Boran] born over the period 2002 to 2006 was constructed. Some of the
batches also included pure Kenya-Boran cattle, or N’Dama x Kenya- Boran F1 animals. Each batch was exposed as
yearlings to natural field trypanosomosis challenge over a period of about one year; the entire challenge period
extending from December 2003 to June 2007. Performance of the animals was evaluated by weekly or biweekly
measurements of body weight, packed blood cell volume (PCV), parasitemia score, and number of trypanocide
treatments. From these basic data, 49 phenotypes were constructed reflecting dynamics of body weight,
packed cell volume (PCV) and parasitemia under challenge.
Results: Females were distinctly more trypanotolerant than males. F1, backcross and pure Kenya- Boran animals
ranked in that order with respect to trypanotolerance. Overall batch effects were highly significant (p<0.001)
for most traits, and were generally more significant than the gender or genetic type effects. The superior
trypanotolerance of the F1 animals was expressed in all three components of animal defense strategies against
pathogens: Avoidance resistance, and tolerance.
Conclusions: The results show that trypanotolerance derived from the N’Dama is expressed under field conditions;
and that the trait is primarily additive in nature, being expressed in heterozygous condition and in a three-quarters
Boran genetic background. The results further, underscore the complexity of the trait in the field manifesting all
three host disease-control strategies, and show the importance of gender and local environmental conditions in
determining response to challenge.
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About 60 million African cattle [1] are at risk for Trypa-
nosomosis (Nagana), caused by the protozoan parasites:
Trypanosoma congolense, T. vivax, T. brucei and trans-
mitted by Glossina tsetse-fly species. This disease is a
constraint to livestock production in Sub-Saharan Africa
as effective control methods are not available. However,
a degree of resistance to the disease (trypanotolerance)
has been reported in some African livestock breeds,
among them the N’Dama (ND) longhorn of West Africa
[2-6], Orma Boran [7-9] and the Zebu of East Africa
[10]. Trypanotolerant quantitative trait loci (QTL) were
identified in an F2 ND × Kenya-Boran (KB) cattle pop-
ulation under artificial challenge with a single 1180
T. congolense clone [11]. This experiment identified
20 trypanotolerant QTLs, eight of which derived their
higher trypanotolerance from the Boran, raising the
exciting possibility of developing a synthetic breed of
higher trypanotolerance than either of the parental
breeds (KB or ND). In this context, the backcross
(denoted BCB) of the F1 (ND x KB) to the KB is of
particular interest, as a potential base population for
development of a synthetic breed combining trypanoto-
lerance from the ND and Boran and favourable produc-
tion traits (primarily body weight) from the Boran; or as
a way station for development of a trypanotolerant
Boran by marker assisted introgression from the ND.
However, in order to translate these results into practical
use, it is necessary to ascertain that the QTL responsible
for ND trypanotolerance are indeed expressed in a BCB
population under field and natural challenge situations
with diverse tsetse intensities and trypanosome species
and subspecies, coupled with other stressful environ-
mental conditions. We here describe the construction
of such a BCB population, and its response to natural
field challenge by trypanosomosis under a variety of
field conditions.
Results
Test-year environment effects (batch effects)
Table 1 shows the results of the fixed effects analysis,
including the actual mean trait values of the BC1 males
of Batch 1 (n=22) that served as reference group for the
fixed effects analysis. Also shown are the estimated
mean trait values for each batch, corrected for gender
effects; and the maximum significance of the batch
effects relative to the reference group; the average values
for each trait across all batches (MeanAll); and the
within-batch and between-batch coefficients of variation
for each trait across all batches.
Differences among batches were highly significant for
almost all traits, showing the importance of local envir-
onment on infection and course of the disease. WIC
was distinctly lower for Batch 5 compared to the otherbatches, and this resulted in lower values for most of the
traits that were a function of time (i.e., STR, TPS, and
NINF). Batch 5 also experienced a severe drought that
compromised the nutritional status and general health
of the animals. This resulted in a rapid decrease in PCV
under second infection and need for early treatment
(DT2=8.01 days). For the same reason, Batch 5 had the
lowest proportion of non-treated parasitemia detections
(NIT= 0.32) and distinctly lower average weight gain
(8.24 kg, Table 1). The season of exposure for Batch 4
was one with a very low tsetse challenge. Consequently,
DT1, DC1A, DF2 and DCIB were very high for this
Batch. Batches 1, 2 and 6 were high tsetse challenge sea-
sons, taking only 2 weeks until first infection (DF1),
while Batches 3, 4 and 5 took 3–4 weeks. Batches 1, 2
and 6 also presented higher MPAR, indicating that
under high challenge not only does infection occur more
rapidly, but parasitemia load is also greater. The animals
in Batches 1 and 2 were the first animals in the experi-
ment and were allowed more time in acclimatizing
before exposure to tsetse. Consequently, the animals in
these batches were slightly older (by a few months) than
in the other batches and their WT1 was correspondingly
greater. They also experienced the highest average
weight gain of 32 kg from the initial WTI to final weight
in the study period.
Coefficients of variation (CVs) were generally con-
siderably higher within batches (median, 40-50%) than
between batches (median, 10-20%). This is expected,
since the averaging effect of many individuals in each
batch will tend to level variation among batches relative
to variation within batches. CVs were quite high for
the parasitemia, infection and treatment traits (50-90%
within-batches; 10-50% between-batches). This is plaus-
ible, considering the multiple intrinsic, environmental
and chance factors that affect these traits. CVs were
considerably lower for the PCV and WT traits (<30%
within-batches; <10% between-batches), implying that
these are more directly determined by intrinsic animal
factors. Exceptions to this were the traits involving
differences or changes (PC1F1, WT1F1, WT1T1, WTC,
WTC-W, WT1F1T1 and WTT1F2). For such traits, the
MeanAll value (the denominator of CV) is low, since
the change for the individual animal can be positive or
negative; while standard deviation (the numerator of
CV) is large. The net effect of a small denominator and
large numerator is a very high CV. Thus, for these traits
CVs are not meaningful.
The course of infection and treatment in an “average”
BCB animal
Based on the gender-corrected MeanAll trait values
across all batches (Table 1), the average BCB individual
was infected 21 days after exposure (DF1) and required
Table 1 Two-Way (batch and gender) ANOVA estimates of batch effects: Ref-mean, mean of BC males of Batch 1 (n=22)





(%)61 2 3 4 5 6
WIC 60.32 55.57 55.90 57.43 53.37 34.13 43.62 50.00 18.43 51.50
STR 20.05 19.36 18.40 18.18 16.18 8.05 18.58 *** 16.46 25.84 72.40
STRTV 15.77 15.43 14.42 13.15 11.48 5.45 15.44 *** 12.56 30.24 81.80
STRTC 4.27 3.93 3.98 5.03 4.70 2.60 3.14 3.90 23.49 61.30
TPS 50.05 47.70 51.31 37.25 29.80 16.13 41.85 *** 37.34 34.50 93.20
MPAR 2.50 2.46 2.79 2.05 1.84 2.00 2.25 *** 2.27 21.62 54.20
%PARD 0.33 0.40 0.31 0.29 0.33 0.15 0.45 *** 0.32 31.35 94.10
NINF 5.46 4.56 4.14 4.32 3.98 3.57 4.01 *** 4.10 8.23 44.40
NT 5.32 4.36 4.05 4.92 4.53 4.38 4.67 4.49 6.64 27.30
NTI 2.82 1.95 2.22 2.80 2.34 2.23 2.02 ** 2.26 13.28 33.30
NIT 0.72 0.74 0.79 0.73 0.77 0.32 0.74 *** 0.68 25.90 68.50
MNT 0.09 0.10 0.06 0.07 0.06 0.17 0.10 *** 0.09 44.08 119.20
MNT1 0.05 0.03 0.03 0.04 0.03 0.07 0.04 ** 0.04 39.82 96.40
DF1 14.27 14.23 15.21 28.86 26.59 24.38 15.40 *** 20.78 31.54 70.20
DT1 18.68 23.50 35.41 29.62 68.18 25.34 30.23 *** 35.38 46.92 143.20
DC1A 32.96 37.72 51.00 58.79 96.44 51.39 45.17 *** 56.75 36.43 113.40
DF2 31.46 37.51 23.73 35.65 57.53 40.13 29.27 *** 37.30 31.00 93.10
DCIB 50.14 61.05 55.43 61.12 129.14 66.71 59.65 *** 72.18 38.98 112.30
DT2 33.19 42.24 57.32 51.99 33.82 8.01 17.78 *** 35.19 54.88 146.40
DC2A 64.52 77.36 79.76 87.79 95.98 47.51 49.63 ** 73.00 27.45 68.40
DC12 97.86 113.48 122.16 145.41 195.68 97.73 95.03 *** 128.25 29.45 80.10
PCI 31.12 32.34 29.72 36.61 29.55 31.84 30.93 *** 31.83 8.14 22.30
MPC 24.10 24.48 24.50 25.01 25.07 22.54 24.22 *** 24.30 3.81 10.50
MXPC 33.14 33.41 34.42 35.45 33.45 29.73 35.93 *** 33.73 6.56 18.40
MNPC 15.64 16.04 15.48 14.84 16.05 15.49 15.54 15.57 2.87 7.80
PCSR 30.32 30.59 32.51 29.63 29.27 25.51 35.24 30.46 10.76 32.00
PCF1 26.18 26.27 28.33 23.44 29.05 22.58 30.93 *** 26.77 12.26 31.20
PCT1 17.46 17.56 16.63 15.79 17.57 18.50 17.30 *** 17.22 5.37 15.80
PCF2 25.46 24.74 25.33 25.79 27.01 22.91 25.74 ** 25.25 5.41 16.10
PCT2 17.38 17.35 16.40 17.18 18.59 18.17 17.69 * 17.57 4.39 12.50
PCIF1 −4.94 −6.07 −1.39 −13.17 −0.51 −10.46 0.01 *** −5.26 105.94 259.60
PCF1T1 −8.73 −8.70 −11.31 −7.32 −11.65 −3.86 −13.64 *** −9.42 37.44 103.80
PCIT1 −13.66 −14.78 −12.87 −20.78 −11.66 −14.32 −13.63 *** −14.67 21.73 63.00
PCT1F2 8.00 7.33 8.70 10.00 9.25 4.54 8.15 * 8.00 24.05 67.30
WTI 204.32 194.86 196.58 167.93 157.03 150.34 143.66 *** 168.40 13.44 35.70
MWT 201.49 188.40 198.00 199.11 167.79 153.95 164.51 *** 178.63 10.67 3.00
MXWT 235.82 217.73 230.73 235.31 195.19 176.42 195.99 *** 208.56 11.06 3.00
MNWT 171.09 161.86 166.67 161.32 138.94 133.73 130.77 *** 148.88 10.82 3.00
WTF1 191.84 181.36 182.72 181.81 150.26 151.08 152.56 *** 166.63 10.09 2.00
WTT1 178.09 167.19 175.67 167.48 174.40 135.07 158.70 *** 163.08 9.20 3.00
WTF2 181.82 176.73 191.84 176.97 167.09 150.66 146.29 *** 168.26 10.28 3.00
WTE 231.19 215.90 201.50 197.16 164.16 140.12 168.33 ** 186.92 2.88 22.20
WTIF1 −9.78 −13.60 −11.03 15.04 −1.35 −2.12 15.37 *** 0.38 3244.26 258.00
WTIT1 −27.71 −26.88 −25.48 −0.15 6.01 −22.26 9.24 *** −9.92 168.58 37.00
WTC −2.83 −6.46 1.41 31.19 10.76 3.62 20.86 *** 10.23 190.73 42.00
WTC-W 0.03 −0.36 0.41 0.92 −0.24 −3.85 0.85 *** −0.38 469.69 152.00
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Table 2 Average overall weight gain (WG) by batch1
Batch Type2 No.3 WG (kg)4 SD5 CV (%)6
1 BCB 39 31.72 29.07 91.67
2 BCB 34 31.76 29.23 92.03
3 BCB 32 23.72 29.21 123.14
4 BCB 19 24.68 27.33 110.73
KB 13 36.58 29.99 82.01
5 BCB 17 8.24 22.95 278.68
KB 10 4.20 12.02 286.11
6 BCB 39 24.46 32.02 130.92
F1 35 39.82 29.66 74.47
1The average overall weight and coefficient of variation is for BC, KB and
F1 cattle from initial weight (WTI) to the final weight in the last one month
of study.
2Type, genetic type.
3No., number of animals;
4WG, weight gain;
5SD, standard deviation;
6CV, coefficient of variation (%).
Table 1 Two-Way (batch and gender) ANOVA estimates of batch effects: Ref-mean, mean of BC males of Batch 1 (n=22)
(Continued)
WTF1T1 −10.82 −11.26 −1.61 −2.93 8.78 −8.89 −2.93 *** −3.14 222.21 64.00
WTT1F2 4.60 −10.73 17.95 28.99 15.33 55.33 11.99 * 19.81 109.73 23.00
WT1E 35.90 31.72 31.76 23.72 24.68 8.24 24.46 *** 25.77 11.73 114.42
1These animals served as reference group for the fixed effects analysis.
2Actual trait mean values by batch, corrected for gender effects.
3Mean (All), average trait value across all batches (n=192);
4S, maximum significance of an individual batch compared to reference group.
5CV (%)-within, mean within batch coefficient of variation combined across all batches;
6CV%-batch; coefficient of variation among batch means.
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became re-infected 37 days after treatment (DF2), and
was treated again after 35 days (DT2). Thus, there was a
distinct increase in days to infection but no difference in
days from infection to treatment for second infection as
compared to first infection. On average, the individual
underwent 4.10 infection cycles (NINF) in the course of
50 weeks of exposure (WIC), requiring 4.49 treatments
(NT). Out of these, about half (50%) required treatment
when they reached the critical 18% PCV (NT1), while
the remaining treatments were required at a PCV above
the 18% threshold. Positive parasitemic cases (STR) were
detected on average in 16.46 tests across the entire chal-
lenge period of 50 weeks. Thus, on average, 68% of para-
sitemic detections did not result in treatment (NIT).
Out of the total parasitemic detections (excluding mixed
parasitemic infections), 76% were due to T. vivax
(STRTV) and 24% were due to T. congolense (STRTC).
Hence T. vivax was the primary pathogen. This is con-
sistent with previous studies [12] that also implicated
this parasite as the main pathogen in these humid and
sub-humid tsetse infested regions of Africa. The mean
parasitemic score for parasitemic detections (MPAR)
was 2.27, equivalent to 102-103 trypanosome parasites
per μl of blood per positive sample.
On average, PCV decreased by 9.42% (absolute
decrease) from first infection to treatment (PCF1T1) at a
rate of 0.27%/day and recovered (increased) by 8.00%
after treatment at a rate of 0.22% per day. Thus, the lost
PCV due to infection was not completely recovered after
treatment of first infection to the start of second infec-
tion cycle. On average, across the entire challenge
period, mean PCV (MPC) was 7.5% less (absolute value)
than at the beginning of the experiment (PCI), the loss
being due to recurrent infection. Thus, for the entire
year the animals were functioning at only 75% of normal
PCV values.
On average, animals lost 3.14kg (WTF1T1) during the
first infection cycle at a rate of 0.088 kg per day
(WTF1T1/DT1); and gained 19.81 kg (WTT1F2) before
re-infection from the end of the first cycle to beginning
of the second cycle, at a rate of 0.56 kg/day (WTT1F2/
DT2). Since the rate of weight gain after treatment washigher than rate of weight loss, the animals gained net
weight. Thus, treatment had strong positive effect in
regaining lost PCV and allowing further increase in body
weight during challenge.
Average weight gain by batches across the challenge
period (Table 2) ranged from 23.72 to 31.72 kg, with
mean of 29.28 kg, not including Batch 5, where gain was
very low (8.24 kg) due to poor nutritional conditions as
discussed above. Thus, despite infections, the animals
gained weight. This is probably due to the fact that the
animals were about a year old at start of challenge
period and hence still very much in their growth
phase. Standard deviation of weight gain, however, was
29.49 kg, almost exactly equal to the mean. Thus, while
most animals gained weight, an appreciable fraction
(about 15%) lost weight. This may be a reflection of seg-
regation of trypanotolerance loci in the BCB population.
Comparing genetic types, there was a strong interaction
with batch conditions. Thus, in Batch 4, which had very
low tsetse challenge and good environmental conditions,
the KB gained more than the BCB. But in Batch 5, which
was a severe drought year, BCB gained more than KB.
Similarly, in Batch 6, which was a high challenge year,
the F1 gained more than the BCB; although in the
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for weight gain of the BCB to be greater than for the F1.
Female gender effect in relation to trypanotolerance
Table 3 shows a more elaborate analysis for gender
effects (female trait value as a deviation from the corre-
sponding male trait value) and their significance, thanTable 3 Gender effects, female effects as deviation from
the male
Trait BCB (88/104)1 F1 (24/13)1 KB (7/8)1
Effect R/S2 Effect R/S2 Effect R/S2
WIC 1.69 9.82 −12.80
%PARD −0.009 R −16.43 R*** 5.00 S
STR −0.756 R −1.54 R −5.80 R
STRTV −0.205 R −1.08 R −3.10 R
STRTC −0.551 R −0.46 R −2.70 R
TPS −1.673 R −4.11 R −9.90 R
MPAR 0.105 S −0.14 R −0.02 R
NINF −0.826 R*** 0.05 S −1.11 R
NT −0.899 R*** 0.21 S −0.67 R
NTI −0.333 R* −0.31 R −1.16 R**
NIT 0.056 R* −0.07 S 0.12 R
MNT −0.009 R −0.014 R −0.02 R
MNT1 0.003 S −0.0197 R −0.02 R
DF1 3.343 R −9.01 S 40.01 R*
DT1 7.75 R 12.92 R* −31.02 S
DC1A 11.607 R 3.93 R 8.02 R
DF2 10.663 R*** 1.41 R −9.70 S
DCIB 16.255 R* 14.32 R* −41.01 S
DT2 27.934 R 5.13 R −32.02 S
DC2A 35.965 R*** 6.51 R −42.03 S
DC12 43.926 R*** 10.42 R −34.02 S
PCI 1.546 R −0.43 S 1.11 R
MPC 0.904 R 1.09 R 0.89 R
MXPC 1.523 R 1.55 R 0.71 R
MNPC −0.129 R 0.38 R 1.38 R*
PCSR 1.667 R 2.79 R** 1.19 R
PCF1 1.278 R −3.21 S* −2.31 S
PCT1 0.095 R 0.57 R −0.11 S
PCF2 1.074 R* 2.23 R −1.12 S
PCT2 −0.38 S −0.52 S 2.83 R*
PCIF1 −0.535 S −2.75 S −3.90 S*
PCF1T1 −1.47 S*** 3.77 R* 2.19 R
PCIT1 −1.657 S* 0.02 R −1.04 S
PCT1F2 0.991 R 1.36 R −0.71 S
MWT −6.788 −0.12 3.61
***, P<0.01; **, P<0.05; *, P<0.10.
1In parentheses, (M/F) M, number of males and F, number of females on which
the estimates of effects are based; 2Column R/S: R, female shows the more
resistant trait value; S, female shows the more susceptible trait value.our previous study [12]. Also shown is whether the dir-
ection of effect is in the direction of greater tolerance
(R) or greater susceptibility (S). Statistically, the com-
parison is strongest for the BCB as it has the largest
sample size (88 males, 104 females). Across all three
genetic types, 10 tests did not reach significance while
9 tests were significant. Of the significant tests, 7 were
highly significant, (p<0.001), out of which 6 (86%) had
the female as the more resistant gender and only 1 test
(14%) indicated that the male was the more tolerant gen-
der. Two tests were significant (p<0.01) and in both of
these, the female was the more tolerant gender. Thus
overall, 89% of female effects, that were at least signifi-
cant, were in the direction of higher resistance. For the
most part, the traits for which the female presented the
more susceptible phenotype were scattered apparently
randomly among the trait groups. The same holds true
for the phenotypes for which the greater resistance of
the female was statistically significant. Also, the propor-
tion of resistant female phenotypes was highest and
significance was greatest for the large BCB sample as
compared to the smaller F1 and KB samples. These
observations are consistent with the females being more
resistant across all traits, with the scattered instances
where the female presents the more susceptible phe-
notype simply representing sampling variation from a
basically resistant population.
Female resistance was unequivocally expressed in all
three genetic types in most of the phenotypes con-
structed to reflect various aspects of trypanotolerance:
Females took longer (3 and 40 days in BCB and KB,
respectively) to become infected after first exposure
(DF1), 7 and 13 days in BCB and F1 respectively to re-
quire treatment after infection (DT1), 11 days (p<0.001)
and 1 day ( in BCB and F1, respectively ) to become
reinfected (DF2), and 28 days (in BCB) and 5 days
(in F1) to require treatment after re-infection (DT2).
Total number of infections (NINF) and treatments (NT)
were less (p<0.001 in BCB females), and all genetic type
females maintained generally higher PCV values (MPC,
p<0.01 in KB females) across the challenge period. Phe-
notypes reflecting changes in PCV as a result of infec-
tion or treatment were more mixed in direction.
However, these are difficult to interpret. As noted above,
a larger decrease in PCV from infection to treatment
may reflect greater sensitivity, but also may simply
reflect the fact that the more tolerant animal starts with
a higher average PCV, while PCV at treatment is fairly
constant at 18%. Interestingly, weighted average body
weight of the females across all three genetic types, was
only 5.4 kg less than for males. The difference is smaller
than found between males and females at two years of
age, in locations not subject to trypanosomosis chal-
lenge. This too, may reflect better ability of the females
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males, under field conditions.
Table 4 shows effects and their significance and direc-
tion, for the comparison of genetic types. The F1 was
distinctly more tolerant than the BCB, showing the moreTable 4 Genetic type effects
Trait F1 – BCB1 (39/37)4 KB-BCB2 (23/32)4 F1-KB3 (39/23)4
Effect R/S5 Effect R/S5 Effect R/S5
WIC −4.81 −9.95 5.15
%PARD −17.20 R*** 2.05 R −19.25 R***
STR −8.23 R*** −0.75 S −7.48 R**
STRTV −6.29 R*** −1.82 S −4.49 R**
STRTC −1.84 R*** 0.33 S −2.17 S
TPS −16.91 R*** −2.15 S −14.75 R**
MPAR 0.132 S −0.02 S 0.152 S
NINF −1.12 R*** −0.26 S −0.86 R*
NT −0.95 R** −0.05 S −0.91 R*
NT1 −0.372 R* −0.28 S −0.09 R
NIT −0.062 S* −0.39 S*** 0.328 R***
MNT −0.0195 R −0.02 S 0.0005 R
MNTI −0.0119 R −0.02 S 0.0081 R
DF1 15.01 R*** −5.36 R** 20.36 R**
DT1 −10.03 S** −25.41 R 15.41 R
DC1A 4.91 R −30.77 R** 35.67 R**
DF2 1.32 R −13.21 R 14.51 R*
DCIB −8.72 S −38.62 R* 29.92 R*
DT2 −1.61 S 14.41 S −16.01 R
DC2A −1.83 S 1.22 S −3.01 R
DC12 3.01 R −29.58 R* 32.58 R*
PCI 2.65 R** 0.93 S 1.72 R*
MPC 3.87 R*** −1.35 R*** 5.22 R***
MXPC 2.81 R** −2.26 R*** 5.06 R***
MNPC 0.33 R −1.05 R* 1.38 R*
PCSR 2.63 R** −2.95 R*** 5.58 R***
PCF1 −2.15 S* −2.29 R 0.14 R
PCT1 −0.85 S −0.23 R −0.62 R
PCF2 2.86 R** −1.71 R*** 4.57 R***
PCT2 −0.41 S −1.19 R 0.79 R
PCIF1 −4.83 S** −3.25 R −1.55 S
PCF1T1 1.44 R 1.62 S −0.18 S
PCIT1 −3.14 S** −1.22 S −1.92 S
PCT1F2 2.63 R** −2.05 R*** 4.68 R***
MWT −28.21 E*** 15.74 E*** −43.94 E***
1F1-BCB, F1 effects as deviation from BCB, by one-way ANOVA of data from
Batch 6.
2KB-BC, KB effects as deviation from BCB, from combined one-way ANOVA
of data from Batches 4 and 5; 3F1-KB, F1 effects as deviation from KB;
4In parentheses (F1, KB/BCB) number of F1, KB and BCB animals in each
estimate; 5Columns R/S, R indicates that the genetic type with higher
proportion of N’Dama genome is the more resistant; S indicates the reverse.
E, effect is in the expected direction.resistant phenotype in 22 out of the 33 traits tested. The
difference is even more striking when considering non-
significant and significant effects; 15 of the F1 resistant
effects were in this category (8 at p<0.01), while only
4 of the effects indicating greater susceptibility were sig-
nificant or not significant. The effect of ND genome is
less apparent in the comparison of KB to BCB. The BCB
showed the more resistant phenotype in just 17 out of
the 33 traits. However, the difference is much more
apparent when considering non-significant or significant
effects. Ten of the resistant effects were in this group for
the BCB and only one for the KB. The resistance con-
ferred by the ND genome is dramatically expressed in
the F1 to KB comparison. For 28 of the 33 traits the F1
displayed the more resistant phenotype. In 18 instances
the effect was not significant or significant (7 at p<0.01).
None of the traits for which the KB was the more resist-
ant reached significant levels. From the results it is clear
that ND tolerance is displayed strongly in heterozygous
state, but more strongly in the F1 to BCB comparison
than in the BCB to KB comparison. This aspect of
the results will be treated more extensively in the Dis-
cussion section.
Discussion
To the best of our knowledge, this is the first exhaustive
phenotyping study where a cattle population has been
constructed by a defined cross between trypanotolerant
and susceptible breeds, and evaluated under natural
tsetse- and trypanosomosis challenge. Phenotypes mea-
sured included number of infections, treatments, body
weight, PCV and parasitaemia scores. The animals were
allowed to graze in natural pastures and habitats infested
with different species of tsetse flies transmitting different
species and subspecies of trypanosomes, of varying viru-
lence and intensities. This gave an opportunity to assess
the actual behavior of the experimental animals in real
life conditions in the presence of interaction of the
environment, disease (trypanosomosis) and the vector
(tsetse fly). To a large extent it followed the practices of
an average, modern African livestock farmer and there-
fore, the results presented may be assumed to reflect the
situation on the ground.
Test-year environment effects analysis
Overall, test-year environment (batch) effects were
highly significant (p<0.001) for most traits, and were
generally more significant than the gender and genetic
type effects. Very high tsetse fly and trypanosome chal-
lenges were experienced for Batches 1, 2 and 6. Batches
4 and 5 experienced low tsetse fly challenge interspersed
with severe drought. The above two varying conditions
clearly reflected the effect of tsetse challenge and trypa-
nosomes on one hand and food deprivation on the
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1, 2 and 6), animals on average took only two weeks to
be infected (DF1), while under low tsetse challenge
(Batches 4 and 5) animals took 4 weeks to be infected.
Yet, animals in Batches 4 and 5 recorded the lowest
PCV parameters across all batches, showing the effect
of poor nutrition on PCV. This shows why treatment
should be based on both screening for parasites and
PCV determination and not on PCV alone. The batches
that experienced low tsetse challenge but severe drought
(Batches 4 and 5) gained more weight after treatment
and before re-infection (WTT1F2) than those batches
that experienced high tsetse challenge. Thus, in times of
drought it may be prudent to treat undernourished but
‘uninfected’ animals prophylactically for them to achieve
better weight gains.Gender and genetic type effects
Overall, the results of this study identify the female gen-
der, and the genetic types with higher proportion of ND
genome (i.e., F1 vs. BCB, BCB vs. KB, and F1 vs. KB), as
the more trypanotolerant types. Within each specific
comparison (e.g., female vs. male comparison in BCB, F1
and KB; or higher vs. lesser proportion of ND genome
in F1 to BCB, BCB to KB, or F1 to KB comparison),
there are some traits for which the supposedly less try-
panotolerant type manifests the more tolerant pheno-
type. Similarly, within each specific gender or genetic
type comparison, different traits show different levels of
significance (non-significant, significant or highly signifi-
cant). Examination of Tables 3 and 4 shows that degrees
of significance and anomalous trait directions appear to
distribute more or less randomly among the specific
comparisons, and are not concentrated at specific traits.
We believe that the most plausible explanation for these
observations is that they represent sampling variation
from a more trypanotolerant population value. That is,
we propose that on a population basis, the trypanotoler-
ant types (female vs. male, F1 vs. BCB or KB, BCB vs.
KB) are more trypanotolerant across all of the traits, and
variation in observed direction and degree among spe-
cific traits and comparisons are a matter of sampling
variation only. With so many traits, types and compari-
sons, sampling variation in the less tolerant direction
from a more tolerant population coupled with the con-
verse from the less tolerant population, can give a con-
trast for which the more tolerant type have the less
tolerant phenotype. Sampling in the opposite direction
can yield a highly significant difference in the expected
direction in one trait, non-significant difference in the
expected direction for some other trait. Thus, we do not
attribute variation in direction and degree of effect among
the difference specific comparisons as representing truepopulation differences in these attributes, and hence we
will not discuss these differences in detail.
Combining all observations, then, we find that greater
trypanotolerance whether conveyed by female gender or
ND genome is associated with a lower number of posi-
tive trypanosome detections over the entire challenge
period (STR); fewer infection cycles (NINF) and fewer
treatments (NT); more days until first and second infec-
tion after exposure (DF1 and DF2), and from date of
infection to treatment (DT1 and DT2); and higher aver-
age PCV across the entire infection period (MPC). Thus,
this experiment fully achieved one of its primary goals in
showing that trypanotolerance is expressed across the
entire range of a challenge period, and in all aspects
of trypanotolerance.
The finding of greater trypanotolerance of the female
gender is in agreement with previous work reported
[12,13], the latter in Galana ranch involving Orma Boran
cattle where in both cases, it was shown that females
required fewer treatments than their male counterparts.
Also, male vs. female weight-gain difference across the
challenge period was less than the difference between
male and female when reared for a comparable period in
the absence of trypanosomiasis challenge.
Equally, this finding that female gender may be more
trypanotolerant than the male is an important one as it
confirms a similar hypothesis arising from a comparative
study on susceptibility of male and female albino mice
to Trypanosome brucei brucei, whose results suggested
that the female mice were more trypanotolerant than
their male counterparts, due to the fact that the poly-
clonal β-Lymphocyte factor is more active against trypa-
nosomes in females than in males [14]. It has also been
reported that male N’Dama have higher plasma choles-
terol levels than females and susceptible cattle have
higher levels of plasma cholesterol and triglycerides than
trypanotolerant cattle [15]. Reasons for gender differ-
ences between levels of plasma cholesterol and triglycer-
ides in both breeds are not known. However, it has been
postulated that the low plasma lipid values of N’Dama
would suggest that this animal has limited lipid nutrients
to support the growth of trypanosomes, hence develop-
ment of lower parasites during infection [16]. Trypano-
somes take up cholesterol, phospholipids and total lipids
for growth. They also serve as sources of energy for
trypanosome metabolism. These postulations may also
explain the differential expression of trypanotolerance in
the different genders but more exhaustive studies are
needed to confirm this. Other possible explanation for
the effect of gender on trypanotolerance points to the
fact that trypanotolerant QTLs may be sex-linked or
they may be in linkage disequilibrium with sex genes.
All in all, keeping female animals may be an attrac-
tive option in tsetse endemic areas, particularly when
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milk production and less use of draft power by bulls for
field cultivation.
With respect to effect of ND genome, the F1 was
clearly superior to the KB in all aspects of trypanotoler-
ance, with minor exceptions. Since all trypanotolerance
loci in the F1 are present in heterozygous state, this
means that to a large extent, gene action at the trypano-
tolerance loci must have a strong additive component,
in addition to any dominance or recessive effects. This
conclusion differs from that based on QTL mapping in
an F2 population [13], which reported primarily reces-
sive gene action at their mapped trypanotolerance loci.
Those conclusions [13] were based on rather complex
QTL mapping analyses, while the F1 to BCB and BCB
to KB results in the present study, although based on
a smaller sample, are strong and direct. Therefore, we
believe that they should be taken as representing the
actual reality. This means that QTL mapping for trypa-
notolerance based on the BCB should be effective. If try-
panotolerance loci were indeed recessive, they would not
come to expression in the F1 or BCB.
The apparent superiority of the F1 in trypanotolerance
relative to the BCB was greater than the apparent super-
iority of the BCB relative to the KB. The F1 was superior
in 22 of 33 traits, of which 16 were at the significant and
highly significant levels; while the BCB was superior
to the KB in only 17 of 33 traits of which 7 were at the
significant and highly significant levels. Yet on an indi-
vidual locus basis, the expected additive superiority of
the BCB to the KB is the same as the expected superior-
ity of the F1 to the BCB. In the F1, all trypanotolerance
loci are present in all individuals in heterozygous state;
in the BC1 sample, half of trypanotolerance loci are
present in all individuals in heterozygous state; in the
KB, none of the trypanotolerance loci are present. Thus,
across all loci, the additive population value for trypano-
tolerance of the BCB is as far removed from the popula-
tion value of the KB, as the population value of the F1 is
removed from the population value of the BCB. Similar
unexpected results were obtained for mean body weight.
The F1 was distinctly lighter than the KB (−43.94 kg),
indicating an appreciable additive component for gene
effect of body weight loci from the KB. But here too, the
difference between F1 and BCB (−28.2 kg) was almost
twice as great as the difference between BCB and KB
(−15.74 kg). The explanation for these anomalies may lie
in the specific environment of Batches 4, 5 and 6.
Batches 4 and 5, on which the BCB vs. KB comparison
is based were characterized by low tsetse challenge, and
poor nutrition due to drought. This would have reduced
differences due to trypanotolerance and growth rate. In
contrast, Batch 6 on which the F1 to BCB comparison is
based was characterized by high tsetse challenge andgood nutrition. This would have allowed fuller expres-
sion of differences in trypanotolerance and growth rate.
In summary, the BCB individuals demonstrated
increased ability to manage trypanosomosis as compared
to purebred KB and were intermediate to a sample of F1
individuals. This shows a strong additive component to
trypanotolerance loci, validating the use of the BCB as a
mapping population (the results of the QTL mapping
component of the study will be reported separately), and
as a platform for development of a synthetic breed com-
bining trypanotolerance of the ND with body size of the
Boran. In addition to the comparison of genetic types,
the results demonstrate clearly superior trypanotoler-
ance of the female gender as compared to the male
within all three genetic types (KB, BCB and F1), again
supporting our previous study [12] even more as in the
present case many more traits were analyzed. Thus, female
BCB animals may be superior cow-mothers under field
challenge. The study was unique in following a population
under challenge over the course of time, showed that try-
panotolerance was also reflected in the time course of
infection, treatment, recovery and re-infection.
Trypanotolerance and the three components of animal
disease resistance
The defense strategy of a host animal with respect to
disease resistance has three components: avoidance,
which aims to reduce the risk of exposure or infection;
resistance, mediated primarily by the immune system,
which aims to reduce pathogen burden following infec-
tion; and tolerance, which aims to reduce the deleterious
effects of pathogen burden on the host [17]. In a striking
study [18] based on construction of Boran/N’Dama
chimeric twins, it was shown that N’Dama trypanotoler-
ance included both resistance, expressed as ability to
control parasitaemia; and tolerance, expressed as ability
to control anemia. Moreover, control of parasitemia and
control of anemia were shown to be separate traits. All
three defense strategies are exemplified in the F1 to KB
comparisons of the present study and also in our previ-
ous study [12]. The F1 animals had better ability than
KB to control parasitemia, as shown by a lower percent-
age of positive parasitemia scores (%PAR) and lower
total parasitemia score (TPS), exemplifying resistance.
They had better ability than the KB to control the effects
of pathogen burden, as shown by higher mean PCV
across the entire test period (MPC), higher percentage
of parasitemia detections that did not require treatment
(NT1), longer interval from first parasitemic detection
to treatment (T1), and fewer trypanocide treatments
across the challenge period (NT), exemplifying toler-
ance. Finally, as uniquely shown in the present study,
the F1 had better ability to avoid infection, as shown
by delayed onset of first infection (DF1), and greater
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second infection (DF2), exemplifying avoidance.
Conclusions
This study shows that trypanotolerance observed under
highly controlled conditions is also effective under field
challenge. Also, females were distinctly more trypano-
tolerant than males. F1, backcross and Kenya Boran
animals ranked in that order with respect to trypanoto-
lerance, showing clear co- or partial dominance of trypa-
notolerance loci. Overall batch effects were highly
significant (p<0.001) for most traits, and were generally
more significant than the gender or genetic type effects,
showing the importance of local environmental conditions
in determining response to challenge. The superior trypa-
notolerance of the F1 animals was expressed in all three
components of animal defense strategies against infection
by pathogens: Avoidance, resistance and tolerance.
Methods
Ethical approval
ILRI’s Institutional Animal Care and Use Committee
(IACUC) is mandated to review all experimental proce-
dures and experiments on animals within ILRI’s watch
and approve or disapprove. After the committee consid-
ered ethical issues and physical procedures associated
with the housing, feeding, experimentation, and all other
routine matters pertaining to the normal welfare of the
animals, it approved the experimental research reported
here through written permission.
Study site
The field study site was located in Narok District, South-
west Kenya between 10.00’S and 10005’S, and 35005'E
and 35015’E (Figure 1). The altitude of the area ranges
from 1600 to 2130 m above sea level. The study area
is classified as semi-arid, with annual rainfall of 750–
1250 mm. The rain comes in two seasons: the ‘long’
(main) rains in March to May and the ‘short’ rains in
November to December, with two dry periods in January
to February and June to October. The study area is pri-
marily savannah grassland, but has four distinct types of
vegetation patterns: open grassland, wooded grassland,
dense thickets and African acacia genus. There are three
tsetse species in the study area: Glossina swynnertoni,
G. pallidipes, G. fuscepleuris, but the first two species
are predominant. The site is typical of the tsetse infested
arid and semi-arid areas of Kenya and was selected on
the basis of previous observations of high trypanosomo-
sis prevalence in cattle during field surveys by the Kenya
Trypanosomiasis Research Institute (KETRI, Kikuyu,
Kenya). The presence of abundant wildlife is an import-
ant feature of the study area, being part of the 25,000 sq.
km rangelands forming the Mara-Serengeti ecosystem.Breeding and management of the backcross population
In the course of the Hanotte et al. [11] QTL mapping
study, a frozen bank of semen from 13 F1 (ND x KB)
males was established at the International Livestock Re-
search Institute (ILRI, Nairobi, Kenya). The population
from which these F1 sires were derived was constructed
by single pair matings of 4 ND males (ND7, ND8, ND9
and ND10) and 4 KB females (KB1419, KB1688, KB1801
and KB2094) resulting in 13 F1 (ND × KB) males
(henceforth: F1 sires) belonging to four full-sib families
according to their ND sire and KB dam. In the present
study, semen of these 13 F1 males was used to produce
192 backcross (BCB) animals through insemination of
about 200 KB females at the ILRI Kapiti ranch (a tsetse
free zone), over the period of June 2001 to December
2006. Doses of semen from individual sires were used in
rotation so that each successive dose of semen was from
a different sire, in order to maximise equality of sire rep-
resentation over time. As the matings proceeded and
information on successful pregnancies became available,
semen usage patterns were adjusted to maintain, as
much as possible, equal representation of sires among
live-born progeny. At the final count, the four F1 sire-
families were represented by 42, 33, 65 and 52 BCB pro-
geny, respectively (total: 88 males and 104 females,
Table 5).
In creating the animal population for this experiment,
artificial insemination was used. Estrus detection was by
experienced herdsmen who in turn reported to the inse-
minators. Due to cost, estrus synchronization was not
implemented. However, possibly due to inadequacies in
heat detections, numerous repeat inseminations were
required before some of the cows conceived, leading to
overall low conception rates. Consequently, the full
planned numbers of experimental animals could not be
achieved in a single season. This in turn led to exposing
the animals to tsetse and trypanosomosis challenge in
the field in batches, which encountered different weather
conditions and therefore different tsetse fly intensities
and different nutritional conditions. This enabled effect
of variation in environment to be evaluated by calcula-
tion of Batch effects.
Purebred KB calves born contemporaneously with the
BCB calves at Kapiti were included in Batches 4 and 5.
In addition, frozen semen from two ND bulls (ND164
and ND162) was used to inseminate purebred KB dams
at Kapiti to produce F1 calves, born contemporaneously
with the BCB calves of Batch 6. ND164 produced 29 F1s
while ND162 produced 10 F1s to make the total of 39
F1s. The KB and F1 calves were reared alongside their
contemporaneous BCB calves and under the same man-
agement regimes throughout the experiment.
Each calf born in Kapiti was weighed at birth, and sub-
sequently at monthly intervals until transported to the
Figure 1 A map of Kenya showing Narok field study site (the green area shows the mara-serengeti ecosystem).
Orenge et al. BMC Genetics 2012, 13:87 Page 10 of 15
http://www.biomedcentral.com/1471-2156/13/87field site. Each calf was assigned a unique ear tag, a tat-
too on the ear and a brand burned on the rump that
uniquely identified the animal and was associated with
pedigree information on the animal.
Progeny were run as suckler calves with their dams
on natural pasture without feed supplementation. In
accordance with standard ranch management condi-
tions, all cattle were treated with acaricides (Triatix®)
every two weeks to control ticks; vaccinated quarterly
against Foot and Mouth Disease (FMD); and dewormed
both prophylactically and tactically (e.g. in anticipation
of a worm outbreak following the rains) until weaning at
8 to 10 months of age. Male calves were not castrated.
Weaner groups were transported to the KETRI Muguga
ranch before being taken to the KETRI operated challengepastures at Narok ranch. In Muguga, they were again vac-
cinated against FMD and also against Contagious Bovine
Pleuropneumonia (CBPP) and East Coast Fever (ECF),
diseases that are known to be endemic at the Narok ranch,
The BCB progeny were moved to the Narok field site in
six different batches, with start dates between December
2003 and July 2006, and end dates between March 2005
and June 2007 (Table 5). There was considerable overlap
between field challenge dates of the different batches.
Batches 1, 2, 3 overlapped one another to some extent, as
did Batches 3, 4, 5. There was a one-month overlap
between Batches 5 and 6. Each Batch was exposed to
field tsetse challenge over the course of a year or more,
with the exception of Batch 5 that was kept under field
challenge conditions for 239 d.
Table 5 Batch composition by sex and genetic type and
duration of tsetse challenge period
Batch Type Male Female Total Start (m.yr) Days
1 BCB 22 22 44 12.03 389
2 BCB 14 22 36 02.04 391
3 BCB 14 18 32 10.04 402
4 BCB 9 13 22 04.05 374
KB 7 8 15
5 BCB 10 9 19 08.05 239
KB 8 0 8
6 BCB 19 20 39 07.06 305
F1 24 13 37
Total BCB 88 104 192
KB 15 8 23
Type, genetic type: KB, Kenya Boran; F1, F1 product of N’Dama male x KB
female; BCB, Backcross product of F1 male and KB female. Start, month and
year of entry to tsetse challenge; Days, total days on challenge.
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cattle (38 males and 33 females) in Batches 4, 5 and 6;
23 purebred KB (15 males and 8 females) in Batches 4
and 5; and 37 F1 (13 males and 24 females) in Batch 6.
Definition of phenotypes and traits
From the raw phenotypes recorded weekly or biweekly
for each individual (PCV, PAR, BW and NT) various
“traits” were meticulously defined and constructed
making a total of 49 phenotypic traits (Table 6). Many of
the traits included a “time” component, e.g., DF1, days
from first exposure to infection. Traits were classified
into groups as absolute body weight traits (BW), PCV
traits (PC), parasitemia traits (PT), infection cycle traits
(IC), treatment-related traits (TT), body-weight-change
traits (BWC). Traits thought to be associated with trypa-
notolerance were classified with respect to direction of
effect, i.e., as to whether high trait-value indicated a
higher degree of trypanotolerance (H-traits) or low trait-
value indicated higher trypanotolerance (L-traits). For
example, DF1, days to first infection after transfer to
Narok, was classified as an H-trait since a larger number
of days to first infection was an indication that the
animal was more trypanotolerant than one that became
infected after a shorter period. In contrast, MPAR, mean
parasitemic score, was classified as an L-trait, since a
low mean parasitemic score indicated that the animal
was better able to control the parasitemia as compared
to an animal with a higher mean parasitemic score; thus
indicating higher trypanotolerance. Where neither of
these applied, the trait was listed as not relevant to
trypanotolerance (NR). NR-traits included: Total weeks
sampled (WIC); Initial PCV (PCI) and PCV at first
screening (PCSR), which were taken before challenge;
and some traits related to body weight (Traits 35–41),such as Initial Body Weight (WT1), which were thought
to be primarily determined by loci affecting BW rather
than by loci affecting trypanotolerance. For each trait,
Table 6 shows the trait number, definition, trait group,
acronym, direction of effect (H, L or NR), and mode
of calculation.
Most of the defined traits were based on data obtained
in the first two infection cycles, or on averages taken
across all weeks sampled, and hence are more or less
independent of the total number of weeks sampled
(WIC). However, total observed parasitemia infections
(STR), total number of infection cycles (NINF), total
number of treatments (NT and NT1), and total weight
change across the entire challenge period (WTC) can all
be expected to show a linear relationship with WIC.
See, e.g., Figure 2 showing scattergram of STR against
WIC. A clear linear relationship is apparent (R2= 0.487
and r = 0.695). This is expected, as the longer the
animals were exposed the more opportunity they had
to be re-infected and thus present positive detection
of trypanosomes.
On the assumption that for the time-related traits, the
relation of trait value to WIC is approximately linear,
they were standardized to the same challenge period by
dividing by WIC, giving mean trait value per week.
Thus, %PARD = 100*STR/WIC; MNT = NT/WIC;
MNTI = NT1/WIC and WTCW = WTC/WIC.
Phenotyping
All animals in the field were recorded weekly for packed
cell volume (PCV) as a measure of anemia, and for para-
sitaemia score (PAR). PCV was determined by centrifu-
gal techniques [19]. Parasitemia species scoring (whether
T. congolense or T. vivax) was based on morphological
features, while the concentration of parasites per ml
of blood was estimated according to the parasitemia
score [20] after examination of about 50 fields. Body
weight (BW) measures of all animals were obtained
in the morning every two weeks, on an electronic
scale (Griffith Elder, UK) at ± 1 kg. When PCV was at
18% or less, animals were treated with a trypano-
cide (Berenil®) by intramuscular injection at a dose of
7 mg/kg body weight. The number of treatments given
to each animal in any given week (NT) was recorded as
a fourth phenotype.
Estimation of gender and batch effects
Fixed effect analysis of BCB animals for batch and
gender effects
Batch and gender effects expressed as deviation from a
reference group, and their statistical significance were
estimated by a two-way ANOVA with batch and gender
as main effects, using the GLM module of the SAS stat-
istical package (SAS 9.1). For batch and gender effects,
Table 6 Traits analyzed and their definitions and mode of calculation
Noa Gb Tc ACRd Definition Mode of calculation
1 NRk NRk WIC Total weeks sampled Total number of weeks sampled over the entire challenge period,
according to batch number
2 Pe L STR Total observed parasitemia detections Total number of observed weekly positive parasitemia detections
over entire challenge period.
3 Pe L STRTV Total observed T. vivax detections Total number of observed positive T. vivax detections over entire
challenge period.
4 Pe L STRTC Total observed T. congolense detections Total number of observed positive T congolense detections over
entire challenge period.
5 Pe L TPS Sum of parasitemic scores Sum of all parasitemic scores over the entire challenge period
6 Pe L MPAR Mean parasitemic score TPS/STR
7 Pe L %PARD Percentage of weeks animal parasitemic 100*STR/WIC
8 Pe L NINF Number of infection cycles Total number of infection cycles, defined as number of new infections
following initial exposure or treatment.
9 Tf L NT Number of treatments Total number of treatments. If after first treatment PCV was still <18%,
the animal was given a second treatment and this was counted as
two treatments.
10 Tf L NT1 Number of treatments when PCV <18% Total No. of treatments given when PCV <18%
11 Tf H NIT Proportion of non-treated parasitemia detections (STR-NT)/STR
12 Tf L MNT Mean treatments per week NT/WIC
13 Tf L MNTI Mean treatments per week when PCV<18% NT1/WIC
14 IC1,g H DF1 Days from exposure to first infection No. of days from date animal is first exposed to tsetse challenge to date
of first parasitemia detection
15 IC1,g H DT1 Days from first infection to first treatment for that infection No. of days from date of first parasitemia detection to date of first
treatment for that infection (in some cases a second treatment was
needed to control the infection).
16 IC1,g H DC1A Length of first infection cycle, counting from exposure to treatment DF1+DT1; This is length of first infection cycle counting from exposure
to treatment.
17 IC1,g H DF2 Days from first treatment to second infection No. of days from date animal is first treated for first infection to date of
second parasitemia detection (i.e., first parasitemia detection after final
treatment for first infection).
18 IC1,g H DC1B Length of first infection cycle counting from first infection DT1+DF2; This is length of first infection cycle counting from first infection
to second infection (after treatment for first infection).
19 IC1,g H DT2 Days from second infection to treatment for that infection No of days from second parasitemia detection to first treatment for
that infection.
20 IC1,g H DC2A Length of second infection cycle, counting from first treatment for first
infection to first treatment for second infection.
DF2+DT2
21 IC1,g H DC12 Total length of first two infection cycles counting from exposure through
first treatment for second infection.
DF1+DT1+DF2+DT2 = DC1A+DC2A
22 PCh NRk PCI Initial PCV Mean PCV of animal before challenge



















Table 6 Traits analyzed and their definitions and mode of calculation (Continued)
24 PCh H MXPC Maximum PCV Maximum PCV of animal during the entire challenge period
25 PCh H MNPC Minimum PCV Minimum PCV of animal during the entire challenge period
26 PCh H PCSR PCV at first screening PCV of animal when first screened
27 PCh H PCF1 PCV at first infection PCV of animal at first parasitemic detection
28 PCh H PCT1 PCV at the first treatment PCV of animal when first treated after first detection of parasitemia
29 PCh H PCF2 PCV at the second infection PCV of animal when infected for second time
30 PCh H PCT2 PCV at second treatment PCV of animal when treated after second infection
31 PCh H2 PCIF1 PCV change from before exposure to PCV at first infection PCF1-PCI
32 PCh H2 PCF1T1 PCV change from first infection to PCV at first treatment PCT1-PCF1
33 PCh H2 PCIT1 PCV change from before exposure to PCV at first treatment PCT1-PCI
34 PCh L,H3 PCT1F2 PCV change from first treatment to second infection PCF2- PCT1
35 WTi NRk,4 WTI Initial body weight Mean of body weight of animal before challenge (within a month
before exposure)
36 WTi NRk,4 MWT Mean body weight Mean of body weight of animal during entire challenge period
37 WTi NRk,4 MXWT Maximum body weight Maximum body weight during the entire challenge period
38 WTi NRk,4 MNWT Minimum body weight Minimum body weight during the entire challenge period
39 WTi NRk,4 WTF1 Body weight at time of first infection Body weight of animal at time of first parasitemia detection after
initial exposure
40 WTi NRk,4 WTT1 Body weight at first treatment Body weight of animal at first treatment
41 WTi NRk,4 WTF2 Body weight at second infection Body weight of animal at second infection (i.e., at first parasitemia
detection after first treatment)
42 WTi NRk,4 WTE Body weight at end of challenge period Body weight of the animal in the last month of tsetse challenge period
43 WTCj H2 WTIF1 Body weight change from initial body weight to first infection WTF1 - WTI
44 WTCj H2 WTIT1 Body weight change from initial body weight to weight at first treatment WTT1 - WTI
45 WTCj NRk,4 WTC Mean Body weight change during challenge period MWT - WTI
46 WTCj NRk,4 WTC-W Mean Body weight change per week during challenge (WTC)/WIC
47 WTCj H2 WTF1T1 Body weight change from first infection to first treatment WTT1 – WTF1
48 WTCj H2 WTT1F2 Body weight change from first treatment to second infection WTF2 - WTT1
49 WTCj H WT1E Body weight changefrom start to end of challenge period WTE – WT1
atrait number; btrait group; cdirection of effect on trypanotolerance, i.e., whether high (H) or low (L) trait value is associated with greater trypanotolerance; dtrait acronym. Trait groups: e parasitemia; ftreatments;
ginfection cycles; hPCV; ibody weight; jbody weight change; knot primarily related to trypanotolerance.
1 First infection cycle counted from first detection of parasitemia after initial exposure to challenge to treatment of first infection; second infection cycle counted from first detection of parasitemia after treatment of
first infection to treatment for second infection; third infection cycle counted from first detection of parasitemia after treatment for second infection, to treatment for third infection, and so on. If challenge period
ended after infection but before treatment, this was counted as a complete infection cycle.
2Change generally negative. Therefore, a high algebraic value (i.e., small negative-value) means greater trypanotolerance, a low algebraic value (large negative-value) means lower trypanotolerance.
3 If the animal is susceptible there will be a large drop from infection to treatment, and hence a large bounce back after treatment. If the animal is tolerant, there will be a lower drop from infection to treatment
(although still PCV <18%) and hence not so large a bounce back after treatment. Thus, a low value means greater trypanotolerance. However, it could also go the other way – following treatment a susceptible animal
may not recover to the same extent as a tolerant animal.
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Figure 2 Scattergram of number of positive trypanosome cases detected (STR) against weeks in challenge (WIC).
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http://www.biomedcentral.com/1471-2156/13/87the males of Batch 1 served as the reference group, and
batch and gender effects were estimated as deviation of
respective batch or gender mean from the reference-
group mean. This was done separately for each trait. In-
dividual trait values were then corrected for gender and
batch effects, using these estimates of gender and batch
effects. For gender correction, only statistically signifi-
cant (P≤0.05) gender-effect estimates were used. For
batch correction, all batch effect estimates were used for
trait correction, irrespective of statistical significance.
This was done because the overall batch effects were
highly significant for most traits, and were generally
much more significant than the gender effects. Esti-
mated mean values by batch for each trait were com-
puted by adding respective batch effect to the reference
mean value for that trait. In order to obtain a general
picture of the overall behavior with respect to infections
and treatments of the BCB animals across all batches,
a parameter herein referred to as “MeanAll” (Table 1)
was obtained for each trait, by calculating mean batch
effect across all batches and adding this to the value of
the reference group. Within-batch coefficients of vari-
ation (CV-within) were calculated for each trait, by
computing standard deviation (SD) within each batch,
and then mean SD pooled across batches; CV(within) =
pooled SD/MeanAll. This within-batch CV was a meas-
ure of the ability of genetic and environmental factors
varying within a given population and herd-year to affect
trait value. In order to provide a similar parameter for
the effects of between-batch environment on trait value,
the between-batch coefficient of variation was calculated
as CV (Batch) = SD (Between)/MeanAll, where SD
(Between) is the standard deviation of batch effects
across all batches.
Gender and Genetic-type effects on trypanotolerance
Female-gender effects as deviation from the male for the
BCB animals across all six batches, were obtained from
the two-way ANOVA as described above. Female-gender
effects as a deviation from the male among the F1 in Batch
6 and among the KB in Batch 4, were separately analysedby batches, using a one-way ANOVA with gender as main
effect. Genetic-type effects as a deviation from the BCB,
were calculated for KB vs BCB in Batches 4 and 5, and for
F1 vs BCB in Batch 6. Here too, the analyses were done
separately by batches, using a one-way ANOVA with gen-
etic type as main effect, after correcting for gender effects
as obtained from the BCB, KB and F1 analyses.
The estimated effects between BCB and KB with
their SE, were provided separately by ANOVA for Batch 4
and Batch 5 and then combined to a single estimate by cal-
culating the simple unweighted mean of the two batch
effects. SE of the combined effect was calculated as:
SE ðcombined KB effectÞ ¼ ½ðSE2 Batch 4ð Þ
þ SEðBatch5Þ=40:5
The effect of F1 as a deviation from KB was calculated
as: Effect of F1 (as deviation from BC) - effect of KB
(as deviation from BC), with
SE ¼ ½SE2 F1 to BCB effectð Þ
þ SE2ðcombined KB to BCB effect Þ0:5
Statistical significance of differences between genders
and genetic types were tested using absolute z-values =
|D|/SE (D). The corresponding p-value was obtained as
twice the area to the right of z in the standard z-tables
(two-tail test).
Abbreviations
KARI: Kenya Agricultural research institute; KETRI: Kenya Trypanosomiasis
research institute; TRC: Trypanosomiasis research centre; ILRI: International
livestock research institute; QTL: Quantitative trait loci; ND: N’Dama;
KB: Kenyan boran; BCB: Boran backcross; PCV: Packed cell volume; PC: PCV
traits; IC: Infection cycle traits; TT: Treatment related traits; BW: Body weight;
BWC: Body weight change traits; H: High trait value; L: Low trait value;
NR: Not relevant; WIC: Total weeks sampled; PAR: Parastemic scores;
STR: Total observed parasitemia detections; STRTV: Total observed T. vivax
detections; STRTC: Total observed T. congolense detections; TPS: Sum of
parasitemic scores; MPAR: Mean parasitemic score; %PARD: Percentage of
weeks animal is parasitemic.; NINF: Number of infection cycles; NT: Number
of treatments; NT1: Number of treatments when PCV <18%; NIT: Proportion
of non-treated parasitemia detections; MNT: Mean treatments per week;
MNTI: Mean treatments per week when PCV<18%; DF1: Days from exposure
to first infection; DT1: Days from first infection to first treatment for that
infection; DC1A: Length of first infection cycle, counting from exposure to
Orenge et al. BMC Genetics 2012, 13:87 Page 15 of 15
http://www.biomedcentral.com/1471-2156/13/87treatment; DF2: Days from first treatment to second infection; DC1B: Length
of first infection cycle counting from first infection; DT2: Days from second
infection to treatment for that infection; DC2A: Length of second infection
cycle, counting from first treatment for first infection to first treatme, t for
second infection.; DC12: Total length of first two infection cycles counting
from exposure through first treatment for second infection.; PCI: Initial PCV;
MPC: Mean PCV; MXPC: Maximum PCV; MNPC: Minimum PCV; PCSR: PCV at
first screening; PCF1: PCV at first infection; PCT1: PCV at the first treatment;
PCF2: PCV at the second infection; PCT2: PCV at second treatment;
PCIF1: PCV change from before exposure to PCV at first infection; PCF1T: PCV
change from first infection to PCV at first treatment; PCIT1: PCV change from
before exposure to PCV at first treatment; PCT1F2: PCV change from first
treatment to second infection; WTI: Initial body weight; MWT: Mean body
weight; MXWT: Maximum body weight; MNWT: Minimum body weight;
WTF1: Body weight at time of first infection; WTT1: Body weight at first
treatment; WTF2: Body weight at second infection; WTE: Body weight at end
of challenge period; WTIF1: Body weight change from initial body weight to
first infection; WTIT1: Body weight change from initial body weight to
weight at first treatment; WTC: Mean Body weight change during challenge
period; WTC-W: Mean Body weight change per week during challenge;
WTF1T1: Body weight change from first infection to first treatment;
WTT1F2: Body weight change from first treatment to second infection;
WT1E: Body weight change from start to end of challenge period.
Competing interests
None of the co-authors has competing interests.
Authors’ contributions
CO carried out all genotyping, statistical and QTL mapping analyses, and
wrote the article for BMC genetics, LM did the phenotyping, CK provided
some guidance in the initial genotyping process (DNA extraction and
quantification), JG, OH, AK and MS designed the study and provided project
guidance and supervision. SK provided additional project guidance. MS
participated in statistical analyses, and revised and edited the manuscript. All
authors read and approved the final manuscript.
Acknowledgements
The authors thank the U. S. Agency for International Development; Bureau
for Economic Growth, Agriculture and Trade for funding as Project No. C22-
027; Award Number TA-MOU-02, and by grants to ILRI by UK, Japan, EU,
Ireland, Germany and France and the CGIAR.They also thank ILRI’sKapiti
Ranch where the backcross animals were bred and raised till weaning, KARI-
TRC for acclimatizing and preparing the animals (vaccinations) before
introduction to the field in Narok, and Olchoro-oiruwa Ranch for kindly
providing space and pastures for the animals during the experimental
period. The International Livestock Research Institute, ILRI, The Hebrew
University of Jerusalem and University of Haifa provided technical support
for this work.
Author details
1South Eastern University College (A constituent college of the University of
Nairobi), P.O. Box 170–90200, Kitui, Kenya. 2Kenya Agricultural Research
Institute - Trypanosomiasis Research Centre (KARI-TRC), P.O. Box 362, Kikuyu,
Kenya. 3Department of Veterinary Anatomy and Physiology, University of
Nairobi, Nairobi, Kenya. 4School of Biological sciences, University of Liverpool,
Liverpool L69 7ZB, UK. 5International Livestock Research Institute (ILRI),
Nairobi, Kenya. 6Department of Evolutionary and Environmental Biology,
Institute of Evolution, University of Haifa, Haifa 31905, Israel. 7The Centre for
Genetic Analysis and Applications, University of New England, Armidale, NSW
235, Australia. 8School of Biology, University of Nottingham, Nottingham NG7
2RD, UK. 9Department of Genetics, The Hebrew University of Jerusalem,
Jerusalem 91904, Israel.
Received: 5 June 2012 Accepted: 11 October 2012
Published: 17 October 2012
References
1. D’leteren G, Authie E, Wissocq N, Murray M: Exploitation of resistance to
trypanosomes. In Breeding for disease resistance in Farm Animals. Second
edition. Edited by Axford RFE, Bishops SC, Nicholas FW, Owen JB. UK: CAB
International Wallington; 1999:195–216.2. d’leteren GDM, Authie E, Wissocq N, Murray M: Trypanotolerance: An
option for sustainable livestock production in areas of risk from
trypanosomosis (Review). Revue Sci Tech l’office Int Epiz 1998, 17:154–175.
3. d’leteren G, Authie E, Wissocq N, Murray M: Exploitation of resistance to
trypanosomes. In Axford R.F. E; Bishops S. C.; Nicholas F. W. and Owen J. B.
(eds). Breeding for disease resistance in Farm Animals. Second edition. CAB
International Wallington, UK; 1999:195–216.
4. Murray M, Morrison WI, Murray PK, Clifford DJ, Trail JCM: Trypanotolerance:
A review. World Animal Review, 37 (January- March). Rome: Food and
Agriculture organization of the United Nations; 1981:36–47.
5. Murray M, Morrison WI, Whitelaw DD: Host susceptibility to African
trypanosomiasis-trypanotolerance. Adv Parasitol 1982, 21:1–68.
6. Murray M, Dexter TM: Anaemia in bovine African trypanosomiasis.
Acta tropical 1988, 45:389–432.
7. Njogu AR, Dolan RB, Wilson AJ, Sayer PD: Veterinary Records 1985,
117:632–636.
8. Dolan RB: Genetics and trypanotolerance. Parasitology Today 1987,
3:137–143.
9. Dolan RB: The Orma Boran: A trypanotolerant East African Breed. Fifteen
years of research on Galana Ranch in Kenya. Kikuyu, Kenya: Kenya
Trypanosomiasis Research Institute; 1998:96.
10. Mwangi EK, Stevenson P, Gettinby G, Murray M: Variation in susceptibility
to tsetse-borne trypanosomiasis among Bos indicus cattle breeds in East
Africa. In Towards increased use of trypanotolerance: current research and
future directions (G.J. Rowlands & A.J. Teale, eds). Proceedings of a workshop
organised by the International Livestock Centre for Africa (ILCA) and the
International Laboratory for Research on Animal Diseases (ILRAD). Nairobi,
Kenya: ILRADALCA, Nairobi; 1993:81–86.
11. Hanotte O, Ronin Y, Agaba M, Nilsson P, Gelhaus A, Horstmann R, Sugimoto
Y, Kemp S, Gibson J, Korol A, Soller M, Teale A: Mapping of quantitative
trait loci controlling trypanotolerance in a cross of tolerant West African
N’dama and susceptible East African Boran Cattle. Proc Natl Acad Sci U S
A 2003, 100:7443–7448.
12. Orenge C.O., Munga L, Kimwele C, Kemp S, Korol A, Gibson J, Hanotte O,
Soller M: Expression of trypanotolerance in a N’Dama x Boran crosses
under field challenge in relation to N’Dama genome content. BMC Proc
2011, 5(Suppl 4):S23.
13. Bett B, Orenge C, Irungu P, Munga L: Epidemiological factors that
influence time-to-treatment of trypanosomosis in Orma Boran cattle
raised at Galana Ranch, Kenya. Vet Parasitol 2004, 120:45–53.
14. Turay AA, Nwobu GO, Okugun GRA, Igone CU, Adeyeye K, Aghatise KE,
Okpala HO, Talfeng YM: A comparative study on susceptibility of male
and female albino mice to Trypanosome brucei brucei. J Vect Borne Dis
2005, 42:15–20.
15. Ogunsanmi A, Taiwo V, Onawumi B, Mbagwu H, Okoronkwo C: Correlation
of physiological plasma lipid levels with resistance of cattle to
trypanosomiasis. Veterinarski Arhiv 2000, 70(5):251–257.
16. Murray YM, Trail JCM, Black SJ: Genetic resistance to African
trypanosomiasis. J Infect Dis 1984, 149:311–319.
17. Medzhitov R, Schneider DS, Soares MP: Disease tolerance as a defense
strategy. Science 2012, 335:936–941.
18. Naessens J, Leak SGA, Kennedy DJ, Kemp S, Teale AJ: Response of
haemopoietic chimera twin cattle from susceptible and tolerant genetic
backgrounds to experimental infection with Trypanosoma congolense.
Vet Parasitol 2003, 111:125–142.
19. Dargie JD, Murray PH, Murray M, Grimshaw WRI, McIntyre WIM: Bovine
trypanosomosis: the red cell kinetics of N’Dama and Zebu cattle infected
with Trypanosoma congolense. Parasitology 1979, 78:271–286.
20. Paris J, Murray M, McOdimba F: A comparative-evaluation of the
parasitological techniques currently available for the diagnosis of African
trypanosomiasis in cattle. Acta Trop 1982, 39:307–316.
doi:10.1186/1471-2156-13-87
Cite this article as: Orenge et al.: Trypanotolerance in N’Dama x Boran
crosses under natural trypanosome challenge:
effect of test-year environment, gender, and breed composition. BMC
Genetics 2012 13:87.
